3-Methyl-2-oxovaleric acid
|
Basic information |
| Metabolite name | 3-Methyl-2-oxovaleric acid |
 | HMDB0000491 |
 |
C00671 |
 |
439286 |
| Synonyms | 2-Oxoisoleucine; |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | 3-Methyl-2-oxovaleric acid |
| HMDB0000491 |
|
C00671 |
|
439286 |
| Synonyms | 2-Oxoisoleucine; |
| No. of studies | 5 |
|
Relationship between 3-Methyl-2-oxovaleric acid and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M107 | Type1 | CORT group vs. control group | PC12 cell medium | Rat | Down |
| Study M107 | Type1 | Glu group vs. control group | PC12 cell medium | Rat | Down |
| Study M771 | Type1 | CSDS group vs. control group | Faece | C57BL/6J mouse | Up |
| Study M773 | Type1 | antenatal depression group vs. non-antenatal depression group | Serum | Human | Down |
| Study M898 | Type1 | end-stage renal disease with depression group vs. end-stage renal disease without depression group | Serum | Human | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |